Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities


July 10, 2012
65 Pages - SKU: XGBR3958730
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,  |  read more...
$4,500.00
Anti-Tumor Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends,  |  read more...
$2,000.00
Pneumonia Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for pneumonia treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic  |  read more...
$2,000.00
Chemical & Pharmaceutical Plant Construction in Belgium to 2017: Market Databook
5/13/2013 | published by: Timetric
Chemical & Pharmaceutical Plant Construction in Belgium to 2017: Market Databook Synopsis Timetric’s 'Chemical & Pharmaceutical Plant Construction in Belgium to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical  |  read more...
$500.00
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi
5/20/2013 | published by: Access China Management Consulting Ltd.
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by  |  read more...
$750.00
Global Packaging Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry
4/30/2013 | published by: Canadean Ltd
Global Packaging Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry Product Synopsis “Global Packaging Survey 2013–2014: Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry” is a  |  read more...
$2,000.00
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: The risks of investing in Côte d'Ivoire's pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, Côte d'Ivoire posts a better performance, but there  |  read more...
$1,295.00
Croatia Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
Executive Summary BMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to bring about an influx of EU funding in modernising thecountry's  |  read more...
$1,295.00
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low commitment to healthcare,combined with political and economic uncertainties, will remain  |  read more...
$1,295.00
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI  |  read more...
$1,175.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Oncology/Hematology Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!